Isogenica Ltd.

https://www.isogenica.com

Isogenica licenses advanced synthetic antibody libraries and display technologies to enable its partners’ antibodies discovery activities. Isogenica was originally launched to develop and operate its proprietary cell-free, DNA-based display technology, CIS display, as a platform for the discovery of polypeptide biologics. Following the acquisition and development of further technologies, including the Colibra™ DNA library building platform, we now offer opportunities for discovery partnerships with access to our skills and tools, including next-generation, best-in-class antibody libraries such as our camelid VHH (llamdA™), human scFv (Xab™) and Fab (4D Fab™) Systems. These libraries are available for license and screening partnerships, which together with its expertise in the screening of displayed peptide and scaffold libraries, can facilitate client’s biologics discovery needs. *

	Start	2000-01-01 established
	Industry	llamdA™ VHH single-domain antibody library
	Industry 2	protein engineering
	Person	Collier, Adam (Spirea 202007 Head of Buiness Operations before Medimmune + Ablynx + Isogenica + Horizon Discovery)

	Region	Little Chesterford, Saffron Walden
	Country	United Kingdom (GB)
	Street	The Mansion Chesterford Research Park
	City	CB10 1XL Little Chesterford, Essex
	Tel	+44-1799-533680
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Isogenica Ltd.. (2/6/17). "Press Release: Isogenica Announces New Licence Agreement with Maverick Therapeutics". Cambridge.

		Record changed: 2023-07-10